会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 6. 发明授权
    • Furyl derivatives of 16-substituted prostaglandins
    • 16取代前列腺素的呋喃衍生物
    • US4585791A
    • 1986-04-29
    • US667367
    • 1984-11-01
    • Franco FaustiniAchille PanzeriFabrizio OrziEnrico di SalleRoberto Ceserani
    • Franco FaustiniAchille PanzeriFabrizio OrziEnrico di SalleRoberto Ceserani
    • C07D307/38A61K31/557A61P43/00C07C67/00C07C401/00C07D307/54C07D307/935A61K31/34
    • C07D307/935C07D307/54
    • The present invention relates to new furyl derivatives of 16-substituted prostaglandins, to a process for their preparation and to pharmaceutical and veterinary compositions containing them.The new compounds of the invention are optically active or racemic prostaglandins of the following formula (I) ##STR1## wherein R is(1) --OH or --OR' wherein R' is C.sub.1 -C.sub.6 alkyl optionally substituted by phenyl or by a monocycloalkyl group or by a pentatomic or hexatomic heteromonocyclic ring containing at least one heteroatom chosen from O, S and N;(2) ##STR2## wherein each of R" and R"', is independently, hydrogen; C.sub.1 -C.sub.6 alkyl; phenyl; or a pentatomic or hexatomic heteromonocyclic ring containing at least one heteroatom chosen from O, S and N; or R" and R"', together with the nitrogen atom to which they are linked, form a pentatomic or hexatomic heteromonocyclic ring optionally containing a further heteroatom chosen from O, S and N;(3) --W--(CH.sub.2).sub.n --X wherein W is --O-- or --NH--, n is an integer of 1 to 4 and X represents a group --OR' or a group ##STR3## wherein R', R" and R"' are as defined above;one of R.sub.1 and R.sub.2 is hydrogen and the other is hydroxy orR.sub.1 and R.sub.2, taken together, form an oxo group;one of R.sub.3 and R.sub.4 is hydrogen and the other is hydroxy;one of R.sub.5 and R.sub.6 is hydroxy and the other is hydrogen, C.sub.1 -C.sub.6 alkyl, C.sub.2 -C.sub.6 alkenyl, C.sub.2 -C.sub.6 alkynyl, or phenyl;one of R.sub.7 and R.sub.8 is hydrogen and the other is a C.sub.1 -C.sub.4 alkyl or tri-halo-C.sub.1 -C.sub.4 alkyl group;m is an integer of 1 to 3;R.sub.9 is a 2-furyl or 3-furyl group, optionally substituted by one or more substituents chosen from C.sub.1 -C.sub.4 alkyl, C.sub.1 -C.sub.4 alkoxy, tri-halo-C.sub.1 -C.sub.4 alkyl and halogen; and the symbol represents a single bond or a cis double bond.
    • 本发明涉及16-取代的前列腺素的新呋喃衍生物,其制备方法和含有它们的药物和兽药组合物。 本发明的新化合物是下式(I)的光学活性或外消旋前列腺素其中R是(1)-OH或-OR',其中R'是任选被苯基取代的C 1 -C 6烷基或 通过单环烷基或含有至少一个选自O,S和N的杂原子的五原子或六原子杂单环; (2)其中R“和R”'各自独立地为氢; C1-C6烷基; 苯基; 或含有至少一个选自O,S和N的杂原子的五原子或六原子杂单环; 或R“和R”'与它们所连接的氮原子一起形成任选地含有选自O,S和N的另外的杂原子的五原子或六原子异单环; (3)-W-(CH2)nX其中W是-O-或-NH-,n是1至4的整数,X表示基团-OR'或基团,其中R',R“ 和R“'如上所定义; R 1和R 2之一是氢,另一个是羟基或R 1和R 2一起形成氧代基; R3和R4之一是氢,另一个是羟基; R 5和R 6之一是羟基,另一个是氢,C 1 -C 6烷基,C 2 -C 6烯基,C 2 -C 6炔基或苯基; R 7和R 8中的一个是氢,另一个是C 1 -C 4烷基或三卤代-C 1 -C 4烷基; m为1〜3的整数。 R9是2-呋喃基或3-呋喃基,任选被一个或多个选自C 1 -C 4烷基,C 1 -C 4烷氧基,三卤代-C 1 -C 4烷基和卤素的取代基取代; 符号表示单键或顺式双键。